Although glucocorticoid replacement is conventionally administered twice daily, the pharmacokinetics of hydrocortisone would predict very low levels of plasma cortisol by mid-afternoon. This study comparedplasma cortisolday profilesin 7 hypoadrenal patients while on twice daily and thrice daily hydrocortisone replacement. The twice daily regimen was associated with very low levels ofcortisol at 16.00and 18.00 h. This was eliminated by administering the same total dose in a thrice daily regimen. Furthermore, estimates of 'well-being' by visual analogue scale correlated significantly with simultaneous plasma cortisol levels and 5 of the patients expressed a preference for the thrice daily regimen. The findings suggest that thrice daily glucocorticoid replacement therapy should be adopted routinely.
Introduction
Corticosteroid replacement therapy is usually based on a twice daily regimen of hydrocortisoneor cortisone acetate. Conventionally two-thirds of the total dose is taken in the morning and the remainder in the evening, average doses of hydrocortisone being 20 mg on rising and 10 mg at suppertlme'r'. This dosage schedule is an attempt to imitate the normal diurnal cortisol rhythm.
Recently several reports have appeared describing the pharmacokinetics of orally administered hydrocortisone s-6 • These suggest that 6 to 8 h after a 20 mg dose of hydrocortisone, plasma cortisol has fallen to very low levels. In our experience many patients on twice daily replacement notice a fall in their wellbeing in the afternoon, some time before their second dose of steroid is due, and it has been our impression that this may be remedied by giving corticosteroid replacement more frequently.
We have, therefore, compared plasma cortisol day curves on twice daily steroid replacement with those on a thrice daily regimen. The total daily dose was not altered. We have also attempted to quantify well-being and to compare this with simultaneous cortisol levels.
Patients and methods
Seven patients gave informed consent to the study. All had adrenal insufficiency as a result of autoimmune Addison's disease or bilateral adrenalectomy for Cushing's disease. Details of individual patients are given in Table 1 . Six patients had been on maintenance thrice daily and one (MS)on twice daily hydrocortisone, the dose schedule having remained constant for each patient for at least one year.
Plasma cortisol day curves
Each patient was assessed on both twice daily and thrice daily steroid replacement. On the first day of the study patients were admitted to the metabolic ward at 08.30 h. Blood pressure and weight were recorded. Hydrocortisone was administered at 09.00, 14.00 and 20.00 h or at 9.00 and 20.00 h. Blood was sampled at 09.00 h, 10.00 h and then two hourly until 20.00 h. Plasma was immediately separated and deep At the end of the first day the alternate replacement regimen was explained. For 6 patients this was twice daily and for one (MS) thrice. Doses are shown in Figure 1 . Some patients initially taking thrice daily replacement were not taking strict one-third fractions of the total dose. When this was the case it was not altered, but all patients when on twice daily therapy took two-thirds of the total dose in the morning and the remainder at night. The alternate therapy was taken for one month and patients then returned to the ward where the above protocol was repeated.
Patients were not blinded as to which regimen they took. It was felt hazardous and unjustifiable to supply placebo steroid tablets. Plasma cortisol was estimated by radio-immunoassay (Farmos Diagnostica),
Well-being
Well-being was assessed throughout the day by means of a 100 mm visual analogue scale which was labelled 'washed out' at one extreme and 'on top of the world' at the other. Patients made marks on separate scales according to theirestimate of well-being at breakfast, lunch, tea and supper times each day for 3 days prior to coming to the ward. Thus 3 estimates were obtained at each time of day and a mean value was derived.
In order to compensate for individual differences in the perception of 'Norm' the mean of all marks made by a patient was calculated. The difference between this mean value and the mean estimate of well-being at a particular time of day then gave a 'corrected well-being score'. In this way a profile of well-being was obtained for each patient throughout the day on both regimens.
Results

Plasma cortisol day curves
Mean cortisol day profiles on each treatment regimen are shown in Table 2 . Unfortunately DD took her 20.00 h hydrocortisone early on the thrice daily regimen; this point has been omitted from subsequent analysis.
The two regimens were compared by Student's paired t-test (two tailed) ( Table 2) . It can be seen that when our patients took their corticosteroid twice daily, plasma cortisol had fallen to very low levels by 16.00 h. On the thrice daily regimen a much more constant level was obtained, being significantly higher at 16.00, 18.00 and 20.00 h. Although plasma cortisol was higher at 12.00 h on twice daily therapy, adequate concentrations were achieved by the smaller initial dose on thrice daily replacement.
Well-being
The means of the corrected well-being scores for all patients are demonstrated in Figure 1 . It can be seen that well-being is lowest just before the first dose of steroid is taken in the morning. It then rises to a maximum at lunch time and falls gradually toward evening. Although the differences between the two regimens do not achieve statistical significance (Student's paired z-test, two-tailed) it is interesting to note that mean well-being values are maximally separated at 16.00 h, the time of maximal difference in plasma cortisol on the two regimens.
Linear correlation between simultaneous cortisol levels and corrected well-being scores was formally tested and a significant relationship demonstrated (r=0.268; P<0.05).
Blood pressure and weight
There was no significant difference in these measurements during treatment with two regimens.
Discussion
Studies of cortisol secretion demonstrate that in normal volunteers, following an early morning peak, levels remain remarkably constant throughout the day until late eveningS· 7 • It would seem desirable, therefore, to attempt to mimic this when undertaking corticosteroid replacement therapy. Our data clearly demonstrate a prolonged and unphysiological nadir in plasma cortisol from mid-afternoon onwards on twice daily dosing. Presumably this would have been still more obvious had the morning dose of hydrocortisone been taken on rising, as is usually the case. Such low levels are undesirable both in terms of the likely effect upon well-being and will additionally leave the patient unprotected in case of sudden stress. We have shown that this can be corrected simply by giving the same total dose of steroid in 3 equal fractions. The smaller morning dose avoids the supraphysiological peak noted with conventional twice daily replacement and levels from 16.00 to 20.00 hare significantly higher on 3 times daily treatment. The kinetics of orally administered hydrocortisone have been well described previously3-S,8 and our data are consistent with these reports.
We have used thrice daily steroid replacement for some time, largely because of comments from patients that they feel 'low' in the mid-afternoon on conventional twice daily therapy. This has been remarked upon in one previous report", This clinical preference explains the strong bias towards thrice daily therapy in our patients at the initiation of the study. Although many physiological and psychological variables must affect well-being, and indeed very high cortisol levels may lower it, we were able to demonstrate a significant correlation between plasma cortisol levels and wellbeing. It is therefore unlikely that the non-randomized recruitment resulted in bias in patients' estimate of well-being.
Although our comparisons of well-being on the two regimens did not achieve statistical significance, patients do seem to feel better in mid-afternoon on the thrice daily regimen (Figure 1) . This is the time at which cortisol concentrations are maximally separated, and would tend to support our clinical impression that well-being deteriorates in the midafternoon on a twice daily regimen and that this may be corrected by thrice daily dosing.
At the end of the study, patients were asked which regimen they would prefer to take on a long-term basis, having tried both. Four of our seven patients expressed a preference for thrice daily dosing because they 'felt better'. Since the end of the study however, one patient (TS) who had initially opted for twice daily replacement has asked to return to thrice daily therapy. The two remaining patients, preferring their hydrocortisone twice daily, liked the convenience of not having a lunch time tablet and felt none the worse for it.
We have demonstrated a significant nadir in plasma cortisol levels on conventional twice daily steroid replacement. This can easily be corrected without altering the total dose by adopting a thrice daily regimen. Patients prefer this treatment and we feel that it should be adopted as routine initial corticosteroid replacement therapy.
